Loading...
Targeted therapies and immunotherapy in non-small-cell lung cancer
Non-small-cell lung cancer is still considered a difficult disease to manage because of its aggressiveness and resistance to common therapies. Chemotherapy remains the gold standard in nearly 80% of lung cancers, but clinical outcomes are discouraging, and the impact on median overall survival (OS)...
Na minha lista:
| Udgivet i: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cancer Intelligence
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4929979/ https://ncbi.nlm.nih.gov/pubmed/27433281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.648 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|